Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank92
3Y CAGR+27.0%
5Y CAGR+24.0%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+27.0%/yr
vs +107.7%/yr prior
5Y CAGR
+24.0%/yr
Recent acceleration
Acceleration
-80.7pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.57 | -32.8% |
| 2024 | 0.86 | +98.4% |
| 2023 | 0.43 | +53.8% |
| 2022 | 0.28 | +9.0% |
| 2021 | 0.26 | +31.1% |
| 2020 | 0.20 | +39.6% |
| 2019 | 0.14 | +833.2% |
| 2018 | 0.02 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |